Suppr超能文献

ATR的缺失选择性地使缺乏ATM的人乳腺上皮细胞对电离辐射和DNA损伤剂敏感。

Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents.

作者信息

Cui Yuxia, Palii Stela S, Innes Cynthia L, Paules Richard S

机构信息

a National Institute of Environmental Health Sciences; National Institutes of Health Research ; Triangle Park , NC USA.

出版信息

Cell Cycle. 2014;13(22):3541-50. doi: 10.4161/15384101.2014.960729.

Abstract

DNA damage response (DDR) to double strand breaks is coordinated by 3 phosphatidylinositol 3-kinase-related kinase (PIKK) family members: the ataxia-telangiectasia mutated kinase (ATM), the ATM and Rad3-related (ATR) kinase and the catalytic subunit of the DNA-dependent protein kinase (DNA-PKcs). ATM and ATR are central players in activating cell cycle checkpoints and function as an active barrier against genome instability and tumorigenesis in replicating cells. Loss of ATM function is frequently reported in various types of tumors, thus placing more reliance on ATR for checkpoint arrest and cell survival following DNA damage. To investigate the role of ATR in the G2/M checkpoint regulation in response to ionizing radiation (IR), particularly when ATM is deficient, cell lines deficient of ATM, ATR, or both were generated using a doxycycline-inducible lentiviral system. Our data suggests that while depletion of ATR or ATM alone in wild-type human mammary epithelial cell cultures (HME-CCs) has little effect on radiosensitivity or IR-induced G2/M checkpoint arrest, depletion of ATR in ATM-deficient cells causes synthetic lethality following IR, which correlates with severe G2/M checkpoint attenuation. ATR depletion also inhibits IR-induced autophagy, regardless of the ATM status, and enhances IR-induced apoptosis particularly when ATM is deficient. Collectively, our results clearly demonstrate that ATR function is required for the IR-induced G2/M checkpoint activation and subsequent survival of cells with ATM deficiency. The synthetic lethal interaction between ATM and ATR in response to IR supports ATR as a therapeutic target for improved anti-cancer regimens, especially in tumors with a dysfunctional ATM pathway.

摘要

对双链断裂的DNA损伤反应(DDR)由3个磷脂酰肌醇3-激酶相关激酶(PIKK)家族成员协调:共济失调毛细血管扩张突变激酶(ATM)、ATM和Rad3相关(ATR)激酶以及DNA依赖性蛋白激酶的催化亚基(DNA-PKcs)。ATM和ATR是激活细胞周期检查点的核心参与者,并在复制细胞中作为防止基因组不稳定和肿瘤发生的有效屏障。在各种类型的肿瘤中经常报道ATM功能缺失,因此在DNA损伤后,细胞对ATR的检查点阻滞和细胞存活的依赖性更强。为了研究ATR在响应电离辐射(IR)时在G2/M检查点调节中的作用,特别是当ATM缺陷时,使用强力霉素诱导的慢病毒系统构建了ATM、ATR或两者均缺陷的细胞系。我们的数据表明,虽然在野生型人乳腺上皮细胞培养物(HME-CCs)中单独耗尽ATR或ATM对放射敏感性或IR诱导的G2/M检查点阻滞影响很小,但在ATM缺陷细胞中耗尽ATR会导致IR后的合成致死性,这与严重的G2/M检查点减弱相关。无论ATM状态如何,ATR的耗尽也会抑制IR诱导的自噬,并增强IR诱导的细胞凋亡,特别是当ATM缺陷时。总体而言,我们的结果清楚地表明,ATR功能是IR诱导的G2/M检查点激活以及ATM缺陷细胞后续存活所必需的。ATM和ATR在响应IR时的合成致死相互作用支持将ATR作为改进抗癌方案的治疗靶点,特别是在ATM途径功能失调的肿瘤中。

相似文献

3
ATR signaling cooperates with ATM in the mechanism of low dose hypersensitivity induced by carbon ion beam.
DNA Repair (Amst). 2015 Oct;34:1-8. doi: 10.1016/j.dnarep.2015.07.001. Epub 2015 Jul 17.
7
Dissecting cellular responses to irradiation via targeted disruptions of the ATM-CHK1-PP2A circuit.
Cell Cycle. 2013 Apr 1;12(7):1105-18. doi: 10.4161/cc.24127. Epub 2013 Mar 5.

引用本文的文献

2
Advances in Targeted Therapy for Metastatic Prostate Cancer.
Curr Treat Options Oncol. 2025 Apr 29. doi: 10.1007/s11864-025-01323-7.
3
ATM in immunobiology: From lymphocyte development to cancer immunotherapy.
Transl Oncol. 2025 Feb;52:102268. doi: 10.1016/j.tranon.2024.102268. Epub 2025 Jan 2.
4
ASPM promotes ATR-CHK1 activation and stabilizes stalled replication forks in response to replication stress.
Proc Natl Acad Sci U S A. 2022 Oct 4;119(40):e2203783119. doi: 10.1073/pnas.2203783119. Epub 2022 Sep 26.
5
'Breast Cancer Resistance Likelihood and Personalized Treatment Through Integrated Multiomics'.
Front Mol Biosci. 2022 Apr 14;9:783494. doi: 10.3389/fmolb.2022.783494. eCollection 2022.
6
Mechanisms of Cancer Cell Death: Therapeutic Implications for Pancreatic Ductal Adenocarcinoma.
Cancers (Basel). 2021 Sep 28;13(19):4834. doi: 10.3390/cancers13194834.
7
The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice.
Genes (Basel). 2021 May 13;12(5):727. doi: 10.3390/genes12050727.
9
Targeting DNA repair in cancer: current state and novel approaches.
Cell Mol Life Sci. 2020 Feb;77(4):677-703. doi: 10.1007/s00018-019-03299-8. Epub 2019 Oct 14.
10
SPOP regulates the DNA damage response and lung adenocarcinoma cell response to radiation.
Am J Cancer Res. 2019 Jul 1;9(7):1469-1483. eCollection 2019.

本文引用的文献

1
Development of synthetic lethality anticancer therapeutics.
J Med Chem. 2014 Oct 9;57(19):7859-73. doi: 10.1021/jm500415t. Epub 2014 Jun 13.
2
Targeting ATR in DNA damage response and cancer therapeutics.
Cancer Treat Rev. 2014 Feb;40(1):109-17. doi: 10.1016/j.ctrv.2013.03.002. Epub 2013 Apr 11.
3
ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status.
Cancer Res. 2013 Jun 15;73(12):3683-91. doi: 10.1158/0008-5472.CAN-13-0110. Epub 2013 Apr 2.
4
Dissecting cellular responses to irradiation via targeted disruptions of the ATM-CHK1-PP2A circuit.
Cell Cycle. 2013 Apr 1;12(7):1105-18. doi: 10.4161/cc.24127. Epub 2013 Mar 5.
7
Targeting DNA repair mechanisms in cancer.
Pharmacol Ther. 2013 Mar;137(3):298-308. doi: 10.1016/j.pharmthera.2012.10.009. Epub 2012 Oct 27.
8
Modulation of DNA repair by pharmacological inhibitors of the PIKK protein kinase family.
Bioorg Med Chem Lett. 2012 Sep 1;22(17):5352-9. doi: 10.1016/j.bmcl.2012.06.053. Epub 2012 Jul 1.
9
The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.
Cancer Biol Ther. 2012 Sep;13(11):1072-81. doi: 10.4161/cbt.21093. Epub 2012 Jul 24.
10
Chk'ing p53-deficient breast cancers.
J Clin Invest. 2012 Apr;122(4):1202-5. doi: 10.1172/JCI63205. Epub 2012 Mar 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验